Target expression details
| Target's General Information | |||||
|---|---|---|---|---|---|
| Target ID | T77190 | ||||
| Target Name | SLIT and NTRK-like family member 6 (SLITRK6) | ||||
| Synonyms | SLITRK6; SLIT and NTRK-like protein 6 | ||||
| Target Type | Clinical trial | ||||
| Gene Name | SLITRK6 | ||||
| UniProt ID | SLIK6_HUMAN | ||||
| Target's Expression Profile in Disease Related Tissue between Patients and Normal People | |||||
| Disease | Bladder cancer | ||||
| Example drug | ASG-15ME | Phase 1 | [1], [2] | ||
| Tissue | Bladder tissue | ||||
| Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual |
Fold-change: -2.93 Z-score: -3.23 P-value: 7.13E-05 |
||||
|
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
|||||
| References | |||||
| REF 1 | ClinicalTrials.gov (NCT01963052) ASG-15ME is a Study of Escalating Doses of AGS15E Given as Monotherapy in Subjects With Metastatic Urothelial Cancer. U.S. National Institutes of Health. | ||||
| REF 2 | NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.